These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Recent progress in therapy for chronic myelogenous leukemia]. Urabe A Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158 [TBL] [Abstract][Full Text] [Related]
6. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia. Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677 [TBL] [Abstract][Full Text] [Related]
7. Approaches to the treatment of chronic myeloid leukemia. Savage DG; Goldman JM Int J Hematol; 1994 Jul; 60(1):1-21. PubMed ID: 7919235 [TBL] [Abstract][Full Text] [Related]
8. [The analysis of failures in the treatment of children with chronic myelocytic leukemia in the studies of Polish pediatric leukemia/ lymphoma group]. Chybicka A; Bogusławska-Jaworska J; Kałwak K; Turkiewicz D; Armata J; Balcerska A; Cwiklińska M; Hicke-Roberts A; Kaczmarek-Kanold M; Kołecki P; Kowalczyk J; Krauze A; Matysiak M; Płoszyńska A; Rokicka-Milewska R; Sońta-Jakimczyk D; Sikorska-Fic B; Wiśniewska-Slusarz H; Wysocki M; Wachowiak J Wiad Lek; 1998; 51 Suppl 4():33-9. PubMed ID: 10731941 [TBL] [Abstract][Full Text] [Related]
9. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167 [TBL] [Abstract][Full Text] [Related]
10. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation. Steegmann JL; Casado LF; Tomás JF; Sanz-Rodríguez C; Granados E; de la Cámara R; Alegre A; Vázquez L; Ferro MT; Figuera A; Arranz R; Fernández-Rañada JM Bone Marrow Transplant; 1999 Mar; 23(5):483-8. PubMed ID: 10100563 [TBL] [Abstract][Full Text] [Related]
12. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells. Schulze E; Krahl R; Thalmeier K; Helbig W Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960 [TBL] [Abstract][Full Text] [Related]
13. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia. Tomás JF; López-Lorenzo JL; Requena MJ; Aguilar R; Steegmann JL; Cámara R; Alegre A; Arranz R; Figuera A; Fernández-Rañada JM Bone Marrow Transplant; 1998 Jul; 22(1):47-51. PubMed ID: 9678795 [TBL] [Abstract][Full Text] [Related]
14. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features. Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800 [TBL] [Abstract][Full Text] [Related]
15. Interferon alpha in the treatment of chronic myelogenous leukemia. Robak T Arch Immunol Ther Exp (Warsz); 1998; 46(6):347-53. PubMed ID: 9883313 [TBL] [Abstract][Full Text] [Related]
16. [Autologous bone marrow transplantation in chronic myelogenous leukemia]. Ogura H; Shirafuji N Rinsho Ketsueki; 1991 Apr; 32(4):386-90. PubMed ID: 2067083 [TBL] [Abstract][Full Text] [Related]
17. [Interferon-alpha in the treatment of chronic myeloid leukemia]. Guilhot F Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394 [No Abstract] [Full Text] [Related]
18. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON). Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916 [TBL] [Abstract][Full Text] [Related]
19. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia]. Xu L; Guo N; Huang X Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):589-91. PubMed ID: 11855148 [TBL] [Abstract][Full Text] [Related]
20. Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase. O'Brien S; Giles F; Talpaz M; Cortes J; Rios MB; Shan J; Thomas D; Andreeff M; Kornblau S; Faderl S; Garcia-Manero G; White K; Mallard S; Freireich E; Kantarjian HM Cancer; 2003 Sep; 98(5):888-93. PubMed ID: 12942553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]